Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Revenue: 2022-2025

Historic Revenue for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $861,000.

  • Orchestra BioMed Holdings' Revenue fell 12.77% to $861,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 6.46%. This contributed to the annual value of $2.6 million for FY2024, which is 4.42% down from last year.
  • Orchestra BioMed Holdings' Revenue amounted to $861,000 in Q3 2025, which was up 2.99% from $836,000 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Revenue registered a high of $1.2 million during Q1 2023, and its lowest value of $253,000 during Q4 2024.
  • Its 3-year average for Revenue is $723,909, with a median of $836,000 in 2025.
  • Its Revenue has fluctuated over the past 5 years, first crashed by 76.25% in 2023, then spiked by 135.56% in 2024.
  • Orchestra BioMed Holdings' Revenue (Quarterly) stood at $1.1 million in 2022, then crashed by 76.25% to $262,000 in 2023, then decreased by 3.44% to $253,000 in 2024, then declined by 12.77% to $861,000 in 2025.
  • Its Revenue was $861,000 in Q3 2025, compared to $836,000 in Q2 2025 and $868,000 in Q1 2025.